| Biotechnology Industry | Healthcare Sector | Mr. Shujiang Wu CEO | SSE Exchange | CNE1000050H0 ISIN |
| CN Country | 629 Employees | 1 Jun 2026 Last Dividend | 6 Jun 2025 Last Split | - IPO Date |
Hangzhou Biotest Biotech Co., LTD., founded in 2008 and headquartered in Hangzhou, China, specializes in the fields of biotechnology and diagnostics. The company is actively involved in the research and development, manufacturing, marketing, and servicing of in vitro diagnostic assays, reagents, and instruments on both domestic and international levels. Hangzhou Biotest Biotech's comprehensive range of products caters to various medical needs including fertility health, cardiology, oncology, inflammation, biochemistry, and infectious diseases. In addition to its human medical products, the company extends its offerings to veterinary testing kits, thereby showcasing its versatility and commitment towards contributing significant advancements in the health sector.